title: Initial experience with linear focused shockwave treatment for erectile dysfunction: a 6-month follow-up pilot study.
abstract: Low-intensity shockwaves (LISW) are known to produce revascularization and have been in evaluation and in use to treat erectile dysfunction (ED). The present single-arm pilot study is aimed to assess the safety and efficacy of a dedicated shockwave device (Renova) on vasculogenic ED patients. Fifty-eight patients with mild to severe ED were treated by LISW and their erectile function was evaluated by the International Index of Erectile Function-Erectile Function Domain (IIEF-EF), Sexual Encounter Profile and Global Assessment Questions questionnaires, at baseline and at 1, 3 and 6 months post treatment. The average IIEF-EF increased significantly from 14.78 at baseline to 21.93 at 3 months post treatment and stabilized at 22.26 at 6 months post treatment. Out of 58 patients, 47 (81%) had a successful treatment. No adverse events were reported during the treatment and the follow-up duration. In conclusion, it suggests that the performance of LISW could add a new advanced treatment for ED.
authors.affiliation: Men's Health Clinic, Amstelland Hospital, Amsterdam, The Netherlands.
authors.forename: Y
authors.initials: Y
authors.lastname: Reisman
authors.affiliation: Urology and Andrology Center, Red Crescent Hospital (RCH), Ramallah, Palestine.
authors.forename: A
authors.initials: A
authors.lastname: Hind
authors.affiliation: Amber Clinic, Klaipėda, Lithuania.
authors.forename: A
authors.initials: A
authors.lastname: Varaneckas
authors.affiliation: Urologickaambulance.cz, Brno, Czech Republic.
authors.forename: I
authors.initials: I
authors.lastname: Motil
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D004597:Electroshock / Q000009:adverse effects / Q000295:instrumentation / Q000379:methods*; D007172:Erectile Dysfunction / Q000628:therapy*; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D010413:Penis; D058986:Phosphodiesterase 5 Inhibitors / Q000627:therapeutic use; D010865:Pilot Projects; D011446:Prospective Studies; D011795:Surveys and Questionnaires; D016896:Treatment Outcome
chemical_list: D058986:Phosphodiesterase 5 Inhibitors